EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Applying Artificial Intelligence to Childhood Obesity: T2DM and MASLD Risk Predictive Models

Marianna Amitrano, Gianluca Mondillo iD, Mario Emiliano, Umberto Paolo Santoro

Diagnostics · 11.08.2026 · 16 (16) · 2533

DOI: 10.3390/diagnostics16162533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 11.08.2026. Verfasst von Marianna Amitrano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pediatrics and Neonatology, Hospital "San Giovanni di Dio", 80027 Frattamaggiore, Italy. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric obesity is a complex, multifactorial pandemic with serious early-onset comorbidities, including prediabetes, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular disorders. While lifestyle modifications and the Mediterranean diet remain primary interventions, artificial intelligence (AI) is emerging as a critical tool for early diagnosis and personalized management. This review evaluates the current role of AI in predicting and treating childhood obesity and its complications. A literature search was conducted on PubMed and Google Scholar for English-language articles published from 2015 onward. Search terms included combinations of keywords related to “obesity”, “pediatric”, “comorbidities” (e.g., MASLD, diabetes), and “artificial intelligence” (e.g., machine learning, deep learning, multi-omics). Eligible study types ranged from original articles to systematic reviews and clinical guidelines. By integrating multi-omic data (genome, epigenome, transcriptome, metabolome, microbiota) with socio-psychological metrics, AI can predict obesity risk and early complications. Machine learning (ML) and deep learning have successfully identified specific metabolites, gut flora alterations, neurological pathways, and metabolic SNPs linked to obesity susceptibility. Furthermore, ML-driven prognostic models enable risk assessment for MASLD or diabetes progression, while specialized software supports remote lifestyle monitoring and tailored dietary interventions. AI has the potential to revolutionize pediatric obesity management through precision medicine. However, challenges regarding data privacy, digital literacy, and equitable access persist. Because current evidence relies heavily on limited and heterogeneous pediatric datasets, large-scale, well-characterized, and externally validated cohorts are essential to establish the clinical applicability of AI models before routine implementation.

Schlagwörter

Stichwörter der Autor:innen

MASLDartificial intelligencechildhood obesitytype 2 diabetes

Autor:innen und Institutionen

  • Unit of Pediatrics and Neonatology, Hospital "San Giovanni di Dio", 80027 Frattamaggiore, Italy.
  • Department of Woman, Child and of General and Specialized Surgery, Università Degli Studi Della Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Department of Public Health, University of Naples "Federico II", 80131 Naples, Italy.

ORCID-Profile: Gianluca Mondillo

Zitieren

APA

Amitrano, M., Mondillo, G., Emiliano, M., & Santoro, U. P. (2026). Applying Artificial Intelligence to Childhood Obesity: T2DM and MASLD Risk Predictive Models. Diagnostics, 16(16), 2533. https://doi.org/10.3390/diagnostics16162533

Vancouver

Amitrano M, Mondillo G, Emiliano M, Santoro UP. Applying Artificial Intelligence to Childhood Obesity: T2DM and MASLD Risk Predictive Models. Diagnostics. 2026;16(16):2533. doi:10.3390/diagnostics16162533

BibTeX
@article{Amitrano2026,
  author = {Amitrano, Marianna and Mondillo, Gianluca and Emiliano, Mario and Santoro, Umberto Paolo},
  title = {Applying Artificial Intelligence to Childhood Obesity: T2DM and MASLD Risk Predictive Models},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {16},
  pages = {2533},
  doi = {10.3390/diagnostics16162533}
}
Kostenlos starten →